Memorandum of Understanding between the Food and Drug Administration, Forensic Chemistry Center and the Federal Bureau of Investigation, 56712-56720 [05-19339]

Download as PDF 56712 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices The estimated burden associated with the information collection requirements for these provisions is 2,114 hours. Dated: September 22, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 05–19394 Filed 9–27–05; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [FDA 225–04–4007] Memorandum of Understanding between the Food and Drug Administration, Forensic Chemistry Center and the Federal Bureau of Investigation AGENCY: Food and Drug Administration, HHS. VerDate Aug<31>2005 16:02 Sep 27, 2005 Jkt 205001 ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration and the Federal Bureau of Investigation (FBI). The purpose of this MOU is to establish the general policies and procedures that will govern administrative, logistical, and operational support to FBI missions including cost reimbursable activities. DATES: The agreement became effective December 22, 2004. FOR FURTHER INFORMATION CONTACT: For the FDA: Fred Fricke, Food and Drug Administration, Forensic Chemistry Center, 6751 Steger Dr., Cincinnati, OH 45237, 513–679– 2700. For the FBI: David L. Wilson, Federal Bureau of Investigation Laboratory, Chemical Biological Sciences Unit, PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 Quantico, VA 22135, 703–632– 7766. In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU. SUPPLEMENTARY INFORMATION: Dated: September 20, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. BILLING CODE 4160–01–S E:\FR\FM\28SEN1.SGM 28SEN1 VerDate Aug<31>2005 16:02 Sep 27, 2005 Jkt 205001 PO 00000 Frm 00092 Fmt 4703 Sfmt 4725 E:\FR\FM\28SEN1.SGM 28SEN1 56713 EN28SE05.031</GPH> Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices VerDate Aug<31>2005 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 16:02 Sep 27, 2005 Jkt 205001 PO 00000 Frm 00093 Fmt 4703 Sfmt 4725 E:\FR\FM\28SEN1.SGM 28SEN1 EN28SE05.032</GPH> 56714 VerDate Aug<31>2005 16:02 Sep 27, 2005 Jkt 205001 PO 00000 Frm 00094 Fmt 4703 Sfmt 4725 E:\FR\FM\28SEN1.SGM 28SEN1 56715 EN28SE05.033</GPH> Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices VerDate Aug<31>2005 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 16:02 Sep 27, 2005 Jkt 205001 PO 00000 Frm 00095 Fmt 4703 Sfmt 4725 E:\FR\FM\28SEN1.SGM 28SEN1 EN28SE05.034</GPH> 56716 VerDate Aug<31>2005 16:02 Sep 27, 2005 Jkt 205001 PO 00000 Frm 00096 Fmt 4703 Sfmt 4725 E:\FR\FM\28SEN1.SGM 28SEN1 56717 EN28SE05.035</GPH> Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices VerDate Aug<31>2005 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 16:02 Sep 27, 2005 Jkt 205001 PO 00000 Frm 00097 Fmt 4703 Sfmt 4725 E:\FR\FM\28SEN1.SGM 28SEN1 EN28SE05.036</GPH> 56718 VerDate Aug<31>2005 16:02 Sep 27, 2005 Jkt 205001 PO 00000 Frm 00098 Fmt 4703 Sfmt 4725 E:\FR\FM\28SEN1.SGM 28SEN1 56719 EN28SE05.037</GPH> Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 56720 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices BILLING CODE 4160–01–C DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [FDA 225–05–3000] Memorandum of Understanding Between the Food and Drug Administration and the National Library of Medicine AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is providing notice of a memorandum of SUMMARY: VerDate Aug<31>2005 16:02 Sep 27, 2005 Jkt 205001 understanding (MOU) between the Food and Drug Administration and the National Library of Medicine (NLM). The purpose of this MOU is to assign responsibilities to FDA’s Center for Drug Evaluation and Research (CDER) and NLM for the distribution of product labeling. DATES: The agreement became effective July 6, 2005, and supplements the agreement signed and dated November 21, 2001, and December 3, 2001, by NLM and CDER representatives, respectively. FOR FURTHER INFORMATION CONTACT: For FDA: Lisa Stockbridge, Food and Drug Administration (HFD–140), 5600 Fishers Lane, Rockville, MD 20857, 301–827–7761; or Catherine Miller, Food and Drug Administration (HFD–140), 5600 PO 00000 Frm 00099 Fmt 4703 Sfmt 4703 Fishers Lane, Rockville, MD 20857, 301–827–7772. For NLM: Simon Liu, Bldg. 38A, rm. 2N221, 8600 Rockville Pike, Bethesda, MD 20894, 301–402– 1698; or Stuart Nelson, Bldg. 38A, rm. B2E17, 8600 Rockville Pike, Bethesda, MD 20894, 301–496– 1495. In accordance with 21 CFR 20.108(c), which states that all written agreements and MOU’s between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU. SUPPLEMENTARY INFORMATION: Dated: September 20, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. BILLING CODE 4160–01–S E:\FR\FM\28SEN1.SGM 28SEN1 EN28SE05.038</GPH> [FR Doc. 05–19339 Filed 9–27–05; 8:45 am]

Agencies

[Federal Register Volume 70, Number 187 (Wednesday, September 28, 2005)]
[Notices]
[Pages 56712-56720]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-19339]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[FDA 225-04-4007]


Memorandum of Understanding between the Food and Drug 
Administration, Forensic Chemistry Center and the Federal Bureau of 
Investigation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
a memorandum of understanding (MOU) between the Food and Drug 
Administration and the Federal Bureau of Investigation (FBI). The 
purpose of this MOU is to establish the general policies and procedures 
that will govern administrative, logistical, and operational support to 
FBI missions including cost reimbursable activities.

DATES: The agreement became effective December 22, 2004.

FOR FURTHER INFORMATION CONTACT: 
    For the FDA: Fred Fricke, Food and Drug Administration, Forensic 
Chemistry Center, 6751 Steger Dr., Cincinnati, OH 45237, 513-679-2700.
    For the FBI: David L. Wilson, Federal Bureau of Investigation 
Laboratory, Chemical Biological Sciences Unit, Quantico, VA 22135, 703-
632-7766.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the agency is publishing 
notice of this MOU.

    Dated: September 20, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
BILLING CODE 4160-01-S

[[Page 56713]]

[GRAPHIC] [TIFF OMITTED] TN28SE05.031


[[Page 56714]]


[GRAPHIC] [TIFF OMITTED] TN28SE05.032


[[Page 56715]]


[GRAPHIC] [TIFF OMITTED] TN28SE05.033


[[Page 56716]]


[GRAPHIC] [TIFF OMITTED] TN28SE05.034


[[Page 56717]]


[GRAPHIC] [TIFF OMITTED] TN28SE05.035


[[Page 56718]]


[GRAPHIC] [TIFF OMITTED] TN28SE05.036


[[Page 56719]]


[GRAPHIC] [TIFF OMITTED] TN28SE05.037


[[Page 56720]]


[GRAPHIC] [TIFF OMITTED] TN28SE05.038

[FR Doc. 05-19339 Filed 9-27-05; 8:45 am]
BILLING CODE 4160-01-C
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.